Lin Celia 4
4 · Vera Therapeutics, Inc. · Filed Aug 23, 2022
Insider Transaction Report
Form 4
Lin Celia
Chief Medical Officer
Transactions
- Award
Class A Common Stock
2022-08-19+12,500→ 12,500 total
Footnotes (1)
- [F1]Represents the number of shares of Class A Common Stock underlying the restricted stock units ("RSUs") under Issuer's 2021 Equity Incentive Plan. One-third of the RSUs vest on August 20, 2023, rounded to the nearest whole share, and the remaining RSUs vest on August 20, 2024, subject to the Reporting Person's continuous service through each vesting date.